TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS). In addition, it is developing TG-1701 (BTK inhibitor), Azer-Cel (allogeneic CD19 CAR T), and TG-1801 (anti-CD47/CD19 bispecific mAb) for B-cell disorders, which are under Phase 1 trials. Geographically, the company generates a majority of its revenue selling BRIUMVI in the United States, with the rest coming from sales in other countries.
Quick Stats
Jul 13, 202659.2
AI Score
HOLD0.72
Volume Ratio
Aug 03, 2026
Next Earnings
17
+ve Days (30d)
13
-ve Days (30d)
TGTX Stock Summary
Last updated Jul 13, 2026
TGTX is currently trading at $55.01, positioned above its 200-day moving average of $35.37, indicating a long-term uptrend. The stock has a 52-week range of $25.28 to $59.3.
Technical Analysis: The 50-day moving average stands at $45.76, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 59.785, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.035, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates TGTX at 59.2/100 with a HOLD recommendation.
TGTX (TG Therapeutics, Inc.) Indicators
Last updated Jul 13, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 59.785 |
| CMF (20) | 0.035 |
| ROC (10) | -1.469 |
| ADX (14) | 45.672 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 3.411 |
| AROONOSC (14) | 28.571 |
| WILLAMS %R (14) | -52.638 |
| MFI (14) | 54.594 |
TGTX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
TGTX Price vs Max Options Open Interest
TGTX Max Change In Options Open Interest
TGTX Options - Sort by Max open Interest (near term)
14th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TGTX Daily Out of Money Options - Sort by Max open Interest (near term)
14th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TGTX Daily In the Money Options - Sort by Max open Interest (near term)
14th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TGTX Most Active Options by Volume(near term)
14th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TG Therapeutics, Inc. is above both 50 Day and 200 Day SMA which is considered Bullish.
TGTX Moving Averages Analysis
TG Therapeutics, Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jul 13, 2026
TG Therapeutics, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jul 13, 2026
TGTX (TG Therapeutics, Inc.) Simple Moving Averages
Moving Averages are last updated Jul 13, 2026
| Days | MA |
|---|---|
| 10 | 55.94 |
| 20 | 54.3 |
| 30 | 49.92 |
| 50 | 45.76 |
| 100 | 38.85 |
| 200 | 35.37 |
TGTX Fundamental Analysis
| P/E (Forward) | 43.8596 |
| P/E (Trailing) | 19.972 |
| Market Cap ($) | 8.7 billion |
| Earnings/Share ($) | 2.86 |
| Net Proft Margin (%) | 0.6595 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 1.5252 |
| EPS Estimate Next Year ($) | 3.0102 |
| WallStreet Target Price ($) | 52.1429 |
| Most Recent Quarter |
TG Therapeutics (TGTX) aired a solid Super Bowl commercial, but some viewers were disappointed as they couldn't find the commercial on the company's website. Despite the mixed reactions, there is speculation that the ticker may see a bump in the following week.
Updated 2026-02-09 07:00:02